CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via erk1/2/pparγ pathway

Oncotarget

Volumn 7, Issue 24, 2016, Pages 36510-36528

  Bai, Xiaoyan ^a   Hou, Xiaoyan ^a,b   Tian, Jianwei ^a   Geng, Jian ^a   Li, Xiao ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b INNER MONGOLIA MEDICAL UNIVERSITY   (China)

Author keywords

CDK5; Diabetic nephropathy; ERK1 2; PPAR ; Tubulointerstitial fibrosis

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; COLLAGEN TYPE 4; CREATININE; CYCLIN DEPENDENT KINASE 5; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P35; ROSCOVITINE; VIMENTIN; GLUCOSE; PROTEIN KINASE INHIBITOR; PURINE DERIVATIVE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ENZYME INACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NITROGEN URINE LEVEL; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEINURIA; RAT; SIGNAL TRANSDUCTION; TUBULOINTERSTITIAL FIBROSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; FIBROSIS; GENETICS; KIDNEY TUBULE; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ADULT; ANIMALS; CELL LINE; CYCLIN-DEPENDENT KINASE 5; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBROSIS; GLUCOSE; HUMANS; KIDNEY TUBULES; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PPAR GAMMA; PROTEIN KINASE INHIBITORS; PURINES; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84978080126     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9058     Document Type: Article

References (29)

1. Lai JY, Luo J, O'Connor C, Jing X, Nair V, Ju W, Randolph A, Ben-Dov IZ, Matar RN, Briskin D, Zavadil J, Nelson RG, Tuschl T, Brosius FC, 3rd, Kretzler M and Bitzer M. MicroRNA-21 in Glomerular Injury. Journal of the American Society of Nephrology: JASN. 2015; 26:805-816.
2. Miller N, Feng Z, Edens BM, Yang B, Shi H, Sze CC, Hong BT, Su SC, Cantu JA, Topczewski J, Crawford TO, Ko CP, Sumner CJ, Ma L and Ma YC. Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy. The Journal of neuroscience. 2015; 35:6038-6050.
3. Brinkkoetter PT, Wu JS, Ohse T, Krofft RD, Schermer B, Benzing T, Pippin JW and Shankland SJ. p35, the non-cyclin activator of Cdk5, protects podocytes against apoptosis in vitro and in vivo. Kidney international. 2010; 77:690-699.
4. Guevara T, Sancho M, Perez-Paya E and Orzaez M. Role of CDK5/cyclin complexes in ischemia-induced death and survival of renal tubular cells. Cell cycle. 2014; 13:1617-1626.
5. Liu W, Zhang Y, Hao J, Liu S, Liu Q, Zhao S, Shi Y and Duan H. Nestin protects mouse podocytes against high glucose-induced apoptosis by a Cdk5-dependent mechanism. Journal of cellular biochemistry. 2012; 113:3186-3196.
6. Steinman RA, Robinson AR and Feghali-Bostwick CA. Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts. PloS one. 2012; 7:e48560.
7. Choi JH, Banks AS, Estall JL, Kajimura S, Bostrom P, Laznik D, Ruas JL, Chalmers MJ, Kamenecka TM, Bluher M, Griffin PR and Spiegelman BM. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature. 2010; 466:451-456.
8. Banks AS, McAllister FE, Camporez JP, Zushin PJ, Jurczak MJ, Laznik-Bogoslavski D, Shulman GI, Gygi SP and Spiegelman BM. An ERK/Cdk5 axis controls the diabetogenic actions of PPARgamma. Nature. 2015; 517:391-395.
9. Li R, Wang Y, Liu Y, Chen Q, Fu W, Wang H, Cai H, Peng W and Zhang X. Curcumin inhibits transforming growth factor-beta1-induced EMT via PPARgamma pathway, not Smad pathway in renal tubular epithelial cells. PloS one. 2013; 8:e58848
10. Lee YJ and Han HJ. Troglitazone ameliorates high glucoseinduced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3beta, Snail1, and beta-catenin in renal proximal tubule cells. American journal of physiology Renal physiology. 2010; 298:F1263-1275.
11. Lopes JP and Agostinho P. Cdk5: multitasking between physiological and pathological conditions. Progress in neurobiology. 2011; 94:49-63.
12. Griffin SV, Hiromura K, Pippin J, Petermann AT, Blonski MJ, Krofft R, Takahashi S, Kulkarni AB and Shankland SJ. Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology. The American journal of pathology. 2004; 165:1175-1185.
13. Piedrahita D, Hernandez I, Lopez-Tobon A, Fedorov D, Obara B, Manjunath BS, Boudreau RL, Davidson B, Laferla F, Gallego-Gomez JC, Kosik KS and Cardona-Gomez GP. Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice. The Journal of neuroscience. 2010; 30:13966-13976.
14. Brinkkoetter PT, Olivier P, Wu JS, Henderson S, Krofft RD, Pippin JW, Hockenbery D, Roberts JM and Shankland SJ. Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells. The Journal of clinical investigation. 2009; 119:3089-3101.
15. Peng HY, Chen GD, Tung KC, Chien YW, Lai CY, Hsieh MC, Chiu CH, Lai CH, Lee SD and Lin TB. Estrogendependent facilitation on spinal reflex potentiation involves the Cdk5/ERK1/2/NR2B cascade in anesthetized rats. American journal of physiology Endocrinology and metabolism. 2009; 297:E416-426.
16. Tassin TC, Benavides DR, Plattner F, Nishi A and Bibb JA. Regulation of ERK Kinase by MEK1 Kinase Inhibition in the Brain. The Journal of biological chemistry. 2015; 290:16319-16329.
17. Janani C and Ranjitha Kumari BD. PPAR gamma gene-A review. Diabetes & metabolic syndrome. 2014; 9:46-50.
18. Cho MC, Lee K, Paik SG and Yoon DY. Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders. PPAR research. 2008; 2008:679137.
19. Walton RG, Zhu B, Unal R, Spencer M, Sunkara M, Morris AJ, Charnigo R, Katz WS, Daugherty A, Howatt DA, Kern PA and Finlin BS. Increasing Adipocyte Lipoprotein Lipase Improves Glucose Metabolism in High Fat Diet Induced Obesity. The Journal of biological chemistry. 2015; 290:11547-11556.
20. Lu X, Bijli KM, Ramirez A, Murphy TC, Kleinhenz J and Hart CM. Hypoxia downregulates PPARgamma via an ERK1/2-NF-kappaB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells. Free radical biology & medicine. 2013; 63:151-160.
21. Tian C, Ye X, Zhang R, Long J, Ren W, Ding S, Liao D, Jin X, Wu H, Xu S and Ying C. Green tea polyphenols reduced fat deposits in high fat-fed rats via erk1/2-PPARgammaadiponectin pathway. PloS one. 2013; 8:e53796.
22. Burns KA and Vanden Heuvel JP. Modulation of PPAR activity via phosphorylation. Biochimica et biophysica acta. 2007; 1771:952-960.
23. Arozal W, Watanabe K, Veeraveedu PT, Ma M, Thandavarayan RA, Sukumaran V, Suzuki K, Kodama M and Aizawa Y. Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-gamma agonist actions. Toxicology. 2011; 279:91-99.
24. Kanaguchi Y, Suzuki Y, Osaki K, Sugaya T, Horikoshi S and Tomino Y. Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis. Nephrology, dialysis, transplantation. 2011; 26:3465-3473.
25. Colangelo T, Fucci A, Votino C, Sabatino L, Pancione M, Laudanna C, Binaschi M, Bigioni M, Maggi CA, Parente D, Forte N and Colantuoni V. MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer. Neoplasia. 2013; 15:1218-1231.
26. Bai X, Geng J, Li X, Yang F and Tian J. VEGF-A inhibition ameliorates podocyte apoptosis via repression of activating protein 1 in diabetes. American journal of nephrology. 2014; 40:523-534.
27. Bai X, Li X, Tian J and Zhou Z. Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes. PloS one. 2014; 9:e96117.
28. Rodrigues T, Matafome P, Santos-Silva D, Sena C and Seica R. Reduction of methylglyoxal-induced glycation by pyridoxamine improves adipose tissue microvascular lesions. Journal of diabetes research. 2013; 2013:690650.
29. Bai X, Geng J, Zhou Z, Tian J and Li X. MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy. Scientific reports. 2016; 6:20475.